StockWatch
·
Major Chemicals
Quarterly ResultAug 6, 2026, 08:33 AM

Aemetis Q2 2026 Revenue Up 20% to $62.7M; Adj. EBITDA $9.7M

AI Summary

Aemetis reported strong financial improvements for the second quarter of 2026, with revenues increasing 20% year-over-year to $62.7 million, driven by growth in its California Ethanol and Dairy RNG segments, including $8.6 million from Section 45Z tax credits. The company achieved a gross profit of $13.5 million and operating income of $5.8 million, significantly improving from losses in the prior year. Adjusted EBITDA also saw a substantial increase to $9.7 million. Aemetis continues to expand its biogas production and is pursuing various financing initiatives, including a potential IPO for its India subsidiary, while also investing in carbon intensity reduction projects.

Key Highlights

  • Q2 2026 revenues increased 20% to $62.7 million, including $8.6 million in Section 45Z tax credits.
  • Operating income improved by $16.4 million to $5.8 million in Q2 2026, compared to a $10.7 million operating loss in Q2 2025.
  • Net loss improved by $14.0 million to $9.4 million in Q2 2026, from $23.4 million in Q2 2025.
  • Adjusted EBITDA was $9.7 million in Q2 2026, a $15.5 million improvement from negative $5.8 million in Q2 2025.
  • Dairy RNG sales volume grew 38% to 146,900 MMBtu in Q2 2026.
  • Ethanol gallons sold increased 12% to 15.5 million gallons in Q2 2026.
  • Two additional biogas dairy digesters are expected to be commissioned in Q3 2026.
  • Company is pursuing multi-track financing, including a potential IPO for its India subsidiary.